Free Trial
NASDAQ:SHLT

SHL Telemedicine (SHLT) Stock Price, News & Analysis

SHL Telemedicine logo
$2.05 0.00 (0.00%)
As of 04/4/2025

About SHL Telemedicine Stock (NASDAQ:SHLT)

Key Stats

Today's Range
$2.05
$2.05
50-Day Range
$1.92
$2.81
52-Week Range
$1.85
$6.08
Volume
N/A
Average Volume
9,528 shs
Market Capitalization
$33.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; and Cardio'B, a portable device to transmit a 12-lead ECG. The company also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monitoring devices, including blood pressure, weighing, oxygen saturation level (TelePulse Oximeter), breath exhalation (TeleBreather), and sugar measuring devices; and TelePress, a remote blood pressure monitoring device for personal use. It offers its telemedicine services and devices to subscribers using electronic and telecommunication technologies. The company serves physicians, hospitals, health insurance funds, and patients. It has a collaboration agreement with Mayo Clinic to evaluate the incidence of emergency department visits, re-hospitalizations, and major adverse cardiovascular events over a period of 90 days after first hospitalization for a heart attack for patients using SmartHeart FDA approved 12 lead ECG; and the Hebrew University of Jerusalem and the Hadassah Medical Center. The company was incorporated in 1986 and is headquartered in Tel Aviv, Israel.

Remove Ads
Receive SHLT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SHL Telemedicine and its competitors with MarketBeat's FREE daily newsletter.

SHLT Stock News Headlines

SHLT SHL Telemedicine Ltd.
Amazon Shocker
Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical technology that could change society forever and make early investors rich.
SHL Telemedicine Ltd (SHLTN)
See More Headlines

SHLT Stock Analysis - Frequently Asked Questions

SHL Telemedicine's stock was trading at $2.65 at the beginning of 2025. Since then, SHLT shares have decreased by 22.6% and is now trading at $2.05.
View the best growth stocks for 2025 here
.

Shares of SHLT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that SHL Telemedicine investors own include Arch Capital Group (ACGL), Adobe (ADBE), Analog Devices (ADI), Alnylam Pharmaceuticals (ALNY), Amgen (AMGN), AstraZeneca (AZN) and Baidu (BIDU).

Company Calendar

Today
4/07/2025
Next Earnings (Estimated)
4/16/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Offices & clinics of medical doctors
Sub-Industry
N/A
Current Symbol
NASDAQ:SHLT
Fax
N/A
Employees
583
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$55.94 million
Cash Flow
$0.04 per share
Price / Cash Flow
54.03
Book Value
$5.21 per share
Price / Book
0.39

Miscellaneous

Free Float
N/A
Market Cap
$33.61 million
Optionable
Not Optionable
Beta
0.11
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NASDAQ:SHLT) was last updated on 4/8/2025 by MarketBeat.com Staff
From Our Partners